Posted on 7/20/17
MTBC Named in 2017 Ranking of the Top 15 Medical Billing Companies in the United States
MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced that it has been ranked as one of . . .
Posted on 7/20/17
Henry Schein Launches New Medical Website
Henry Schein, Inc., (Nasdaq: HSIC) today unveiled a newly designed website for Henry Schein Medical (www.henryschein.com/medical), the company's medical division, and announced an improved e-commerce solution . . .
Posted on 7/19/17
Cyclacel Prices $13.2 Million Underwritten Public Offering
BERKELEY HEIGHTS, N.J., July 19, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC), a clinical-stage biopharmaceutical company using cell cycle, transcriptional regulation and DNA damage response . . .
Posted on 7/24/17
Glenmark Pharmaceuticals Enters Exclusive Agreement with Cyndea Pharma S.L.
Glenmark Pharmaceuticals, a global pharmaceutical company, announced today it has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma S.L., granting exclusive . . .
Posted on 7/19/17
New Jersey Plastic Surgery Center Raises Over $7,000 for Alzheimer's Research & Education
Alzheimer's disease affects 1 in 10 people over aged 65 in the U.S., causing progressive loss of memory and brain function. It can be devastating for . . .
Posted on 7/19/17
PeptiDream and Kleo Pharmaceuticals Announce Collaboration Agreement
PeptiDream Inc., a public Tokyo-based biopharmaceutical company (TOKYO:4587) and Kleo Pharmaceuticals Inc., a New Haven-based company using its proprietary Antibody Recruiting Molecule ("ARM") and Synthetic Antibody . . .
Posted on 7/18/17
OncLive and Targeted Oncology Partner with the Association of Community Cancer Centers
CRANBURY, N.J.--(BUSINESS WIRE)--OncLive® and Targeted Oncology™ are proud to announce they’ve partnered with the Association of Community Cancer Centers (ACCC) as a part of its Strategic . . .
Posted on 7/18/17
Johnson & Johnson: Approval Of TREMFYA Is Huge Win For Shareholders
Recently, the FDA approved Johnson & Johnson's (JNJ) treatment TREMFYA for patients with plaque psoriasis. That means Novartis (NVS), Eli Lilly (LLY), and Valeant Pharmaceuticals (VRX) . . .
Posted on 7/18/17
Pharmacy Times Ranks No. 1 Among Pharmacists in Average Page Exposures
CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times®, the leading media resource for pharmacists and the pharmacy industry, ranked the highest in ad visibility among pharmacy journals for Average Page . . .
Posted on 7/18/17
American Health Council Names Husam Issa, MD, With Admission to Physician Board
NEW YORK, July 17, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to recognize Dr. Husam Issa, an Infectious Disease Specialist at Clear Lake . . .
Posted on 7/17/17
Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter
Pfizer (NYSE:PFE) stands at the top of the mountain when it comes to prescription drug sales. Last year, the big pharma company made $45.9 billion from . . .
Posted on 7/17/17
NYC Dermatologist Bobby Buka Adds Sixth Location in Long Island City
Dr. Bobby Buka and his team at Bobby Buka MD are excited to announce the opening of their sixth location in Long Island City, NY. The . . .
Posted on 7/14/17
Pfizer Announces NDA Filing Acceptance By FDA For XELJANZ
Today, Pfizer (PFE) announced that its supplemental new drug application -- sNDA -- has been accepted for review by the FDA. The review will be on . . .
Posted on 7/14/17
1 Reason Why Cara Therapeutics Ended June Down 11.3%
What happenedCara Therapeutics (NASDAQ:CARA), a clinical-stage biotech developing treatments for pain and chronic kidney disease-associated pruritus (itching), gave investors an absolutely wild ride last month. After . . .
Posted on 7/17/17
Regeneron Announces the 2017 Winners of the Regeneron Prize for Creative Innovation
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the fifth annual Regeneron Prize for Creative Innovation, an award designed to recognize, reward and foster . . .
Posted on 7/13/17
Align Biopharma Expands to 23 Members
NEW YORK--(BUSINESS WIRE)--Align BiopharmaTM, a life sciences industry technology standards group, today introduced 14 leading biopharma companies and technology and service providers as new members. In . . .
Posted on 7/13/17
Will Pfizer Keep Growing Its Dividend?
Pfizer (NYSE:PFE) is one of the largest pharmaceutical companies in the business, and millions of patients have benefited from its medications over the years. From top-selling . . .
Posted on 7/12/17
Can Cara Therapeutics Stock Bounce Back?
It was only a few weeks ago that Cara Therapeutics (NASDAQ:CARA) stock was hitting all-time highs. The company had announced good news from its independent data . . .
Posted on 7/11/17
Former Genspace Director To Launch New Biotech Organization This August
Ellen Jorgensen is back to teach people about biotech. The former director of Genspace has a new organization
Posted on 7/11/17
Should You Fear Talcum Litigation?
The company is being sued by about 1,500 plaintiffs.The science is not settled, some studies do find a connection to cancer cases, some do not.Johnson & . . .
Posted on 7/10/17
Eco Medical Village Limited Signs a $300 Million Term Sheet with Institutional Investor, Milost
ACCRA, Ghana, July 10, 2017 (GLOBE NEWSWIRE) -- Eco Medical Village Limited is pleased to announce that it has executed a $300 million financing term sheet . . .
Posted on 7/10/17
Cellectis: Calyxt Announces Proposed Initial Public Offering of $100.0 Million
ST. PAUL, Minn. & NEW YORK--(BUSINESS WIRE)--Cellectis S.A. (Paris:ALCLS) (NASDAQ:CLLS) and Calyxt, Inc. announced today that Calyxt has commenced a proposed initial public offering of 6,060,606 . . .
Posted on 7/10/17
Better Buy: Amgen Inc. vs. Celgene Corporation
Biotechs don't get to be big biotechs without racking up major successes along the way. That's certainly the case for two of the biggest biotechs around . . .
Posted on 7/7/17
Johnson & Johnson: Where's The Growth Coming From?
Image creditJohnson & Johnson (JNJ) has long been a company that has many cash demands. It pays a sizable dividend, buys back stock by the billion . . .
Posted on 7/7/17
Pfizer: Is It Really That Bad?
A lot of investors seem to be quite pessimistic about Pfizer’s (PFE) future. The loss of exclusivity of certain important brands that are coming up are . . .

